GlassScriptPhysician profile
Muhammad Ali Khan
NPI 1144412859
$22,118.63
in general payments reported to CMS, 2019-2025
15 companies · $706 in 2025
The $706 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $173 · 2020: $53.00 · 2021: $223 · 2022: $10K · 2023: $6,275 · 2024: $4,479 · 2025: $706.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $10K · Food and Beverage: $1,212 · Travel and Lodging: $247.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $10,000.00 |
| Food and Beverage | $1,211.98 |
| Travel and Lodging | $247.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $11,939.49 | 2019-2025 | Aveir, Amplatzer Amulet, Ensite Precision |
| Medtronic, INC. | $5,208.15 | 2022-2025 | Micra, Aurora Ev-Icd Mri Surescan, Mycarelink |
| Boston Scientific Corporation | $3,905.85 | 2024-2025 | Watchman Access System, Emblem Mri S-Icd |
| Biosense Webster, INC. | $591.12 | 2023-2025 | Carto 3 |
| Abiomed | $171.03 | 2022-2024 | Impella |
| E.R. Squibb & Sons, L.L.C. | $103.76 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $42.18 | 2024-2025 | Jardiance |
| Philips North America LLC | $32.19 | 2022 | |
| Novartis Pharmaceuticals Corporation | $28.18 | 2025 | |
| Stryker Corporation | $21.03 | 2025 | Flowtriever |
| Astrazeneca Pharmaceuticals LP | $17.94 | 2025 | Wainua |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $17.17 | 2025 | Lifevest |
| Novo Nordisk INC | $14.76 | 2024 | Wegovy |
| Lantheus Medical Imaging, INC. | $14.63 | 2020 | |
| Janssen Pharmaceuticals, INC | $11.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muhammad Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.